Subscribe to Our Blog. Stay up to date with the latest news and insights.
In clinical trials, efficient monitoring plays a pivotal role in ensuring the success and integrity of research studies. As trial protocols and data management complexity increases, leveraging advanced systems that streamline the monitoring process becomes crucial. Remarque Systems Clinical Trial Management System (CTMS) is a cutting-edge solution that offers a range of key features and…
In the fast-paced world of clinical research, effective management of clinical trials is paramount to success. That’s where Remarque Systems comes in, bringing innovation to the forefront of clinical trial management. In this article, we’ll delve into the features, benefits, and impact of Remarque Systems in streamlining trial operations, enhancing data management, and ensuring compliance.…
The Ultimate Solution for Efficient Study Management In clinical research, effective study management is crucial for success. Clinical Trial Management Systems (CTMS) are pivotal in streamlining various aspects of the research process. Among the top CTMS solutions available today, Remarque CTMS stands out as a comprehensive and powerful tool designed to enhance efficiency, data integrity,…
With safety data being just as important as efficacy findings, the most critical factor in clinical trial success is risk avoidance—and central monitoring is a core component of risk-based monitoring. Traditional monitoring, also known as source data verification, happens long after the event and only examines individual data points—providing no insight into overall study data…
Modern clinical trials generate reams of data from multiple sources, creating enormous information management challenges for sponsors. Today, the growing popularity of decentralized clinical trials (DCTs) only exacerbates the problem. It is not enough to cobble together multiple management systems; these new approaches to trials require new clinical trial management systems (CTMS). A modern CTMS…
Clinical trials have long suffered from a lack of racial and ethnic diversity. There are many reasons—geographic, socio-economic, historic, and educational. Yet the safety and efficacy data which drives them is only helpful if it accurately reflects outcomes in the entire population for whom the product will be prescribed. The recent spotlight on matters of…
Clinical studies are expensive to mount—so given the high stakes, sponsors and contract research organizations (CROs) are under pressure to reach conclusions swiftly but without ever jeopardizing patient safety. One solution: Risk-based strategies that enable sponsors to zero in on issues in real time. Now, new governance underscores continuing regulatory support for—and perhaps even insistence…
When pharmaceutical companies hire a contract research organization (CRO) to manage their clinical trials, they may assume that the trial management includes detailed oversight of data collection and analysis. It does most of the time, but ultimately, the responsibility for data governance remains with the sponsor. This lesson was brought home to many sponsors on…